Chandan Healthcare Limited operates laboratories in India. The company offers pathology services, such as biochemistry, hematology, histopathology, microbiology, and immunology tests, as well as radiology services, including x-rays, ultrasonography, computed tomography (CT) scan, and magnetic resonance imaging services. The company also provides healthcare and diagnostic services. The company was incorporated in 2003 and is based in Lucknow, India.
| Current Price | ₹231.00 |
|---|---|
| Market Cap | ₹583 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 21.5 |
| 52-Week Range | ₹227.00 – ₹236.95 |
| Beta (1Y) | 0.13 |
| Dividend Yield | 0.00% |
| Revenue | ₹81 Cr |
|---|---|
| Net Profit | ₹8 Cr |
| EPS (Basic) | ₹3.07 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Chandan Healthcare Limited is trading at ₹231.00, with a market capitalisation of ₹583 Cr.
Chandan Healthcare Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Chandan Healthcare Limited has a P/E of 21.5.
In Q1 FY27, Chandan Healthcare Limited reported revenue of ₹81 Cr and net profit of ₹8 Cr, with basic EPS of ₹3.07 (consolidated, parsed from the company's exchange filing).